Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care
2007

Breast Cancer Treatment During Late Pregnancy

publication Evidence: moderate

Author Information

Author(s): Richard J Epstein

Primary Institution: The University of Hong Kong

Hypothesis

Is immediate chemotherapy during late-trimester pregnancy beneficial for breast cancer patients?

Conclusion

Deferring chemotherapy until after delivery remains a valid option for certain breast cancer patients during late pregnancy.

Supporting Evidence

  • Recent studies suggest that chemotherapy during the second and third trimesters is generally safe.
  • There is no proven survival benefit from therapeutic abortion compared to delaying chemotherapy.
  • The risks of long-term effects on children exposed to chemotherapy in utero are still unknown.

Takeaway

If a mom has breast cancer while pregnant, she can wait to get treatment until after the baby is born, which might be safer for both of them.

Methodology

A review of relevant studies on breast cancer chemotherapy, pregnancy, and drug safety.

Potential Biases

Clinicians may unintentionally bias patients towards immediate treatment due to perceived urgency.

Limitations

The long-term effects of chemotherapy during late pregnancy on both mother and child are not fully understood.

Digital Object Identifier (DOI)

10.1186/1471-2407-7-92

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication